ISLAMABAD, May 22, 2025 /CNW/ — In a groundbreaking move to elevate clinical diagnostics nationwide, MindHYVE.ai™, a U.S.-based pioneer in orchestrated agentic AI and swarm-intelligent systems, has signed a formal Memorandum of Understanding (MoU) with Islamabad Diagnostic Centre (IDC). The collaboration will see the deployment of Chiron and Ava-AutoNarrator™—two proprietary, AGI-powered agents—across IDC’s core diagnostic workflows.

Initially launching at flagship centers in Islamabad (F-8 Markaz) and Lahore (DHA Phase 4), the pilot will introduce a multi-agent diagnostic intelligence layer, enhancing decision precision, speed, and reproducibility in radiology and laboratory services.

“This isn’t just AI—it’s agentic intelligence in action,” said Belal Faruki, Founder & CEO of MindHYVE.ai™. “By fusing swarm intelligence with domain-specific reasoning models, we’re equipping clinicians with AI collaborators that learn, adapt, and elevate patient outcomes—ethically and transparently.”

Key Innovations:

Chiron – A medical diagnostic reasoner, part of MindHYVE.ai™’s Ava-Agent architecture, performs pre-diagnostic inference and real-time anomaly detection across radiological and laboratory datasets.Ava-AutoNarrator™ – A semi-autonomous narrative generation agent, trained on clinical ontologies, that synthesizes structured reports aligned with ICD and HL7 standards.Agentic Coordination Layer – MindHYVE.ai™’s Swarm AI Framework orchestrates agents in real-time—enabling self-organization, priority optimization, and contextual reasoning across patient records.Secure PACS/LIS Integration – Seamless, encrypted integration with IDC’s Picture Archiving and Communication Systems (PACS) and Laboratory Information Systems (LIS).

Three-Phase Rollout Strategy:

Phase 1 – Ground Launch: Initial deployment, radiologist/lab team onboarding, and system calibration.Phase 2 – Reasoner Tuning: AGI model refinement, cross-clinic feedback loops, and clinical data harmonization across 5–7 IDC locations.Phase 3 – Nationwide Readiness: DRAP-compliant licensing, agent swarm scaling, and full-stack intelligence across IDC’s 130+ branches.

Ethical Intelligence Commitment

All systems will be governed under MindHYVE.ai™’s Ethical AGI Protocol, including:

Human-in-the-loop validationEncrypted patient data pathwaysCollaborative oversight with DRAP and PNACExplainable diagnostic decisions using Ava-Fusion™ reasoning models

“MindHYVE.ai™’s orchestrated AGI reflects our vision of scalable, accessible diagnostics,” said Dr. Rizwan Uppal, Founder & CEO of IDC. “This alliance ushers in a new era of intelligent healthcare, anchored in ethics and excellence.”

About MindHYVE.ai™

Headquartered in Newport Beach, California, MindHYVE.ai™ builds domain-specific AGI agents, multi-agent orchestration systems, and the Ava-Fusion™ family of reasoning models—driving intelligent transformation in diagnostics, infrastructure, and national systems.

Website: www.mindhyve.ai | Email: hello@mindhyve.ai | Contact: +1 (949) 200-8668

Media Contact
Marc Ortiz
Email: marc.ortiz@mindhyve.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/mindhyveai-and-islamabad-diagnostic-centre-forge-strategic-alliance-to-launch-agi-powered-diagnostic-intelligence-across-pakistan-302463826.html

SOURCE MindHYVE.ai, Inc.

The K-beauty shampoo developed by a world-renowned scientist from MIT has become a hot topic following its launch on Taiwan’s Momo Home Shopping channel

Clinically proven: one use increases hair thickness by 19.22% and volume by 87.27%

100% vegan formula, Dermatest “Excellent” rating, eco-friendly packaging—epitomizing clean beauty

TAIPEI and SEOUL, South Korea, May 23, 2025 /PRNewswire/ — The Korean hair loss care brand Grabity, co-developed by world-renowned MIT scientist Professor Haeshin Lee and researchers from KAIST (Korea Advanced Institute of Science and Technology), officially launched in Taiwan on May 22 through Momo TV Shopping, where it received an explosive response—selling out mostly during its debut broadcast.

The live show aired at 8 PM on the 22nd, hosted by Sharon Tsui, a prominent Momo TV Shopping personality. Tsui emphasized the product’s scientific backing throughout the segment. The entire stock exhausted shortly in record time, and both Momo’s website and customer service center were soon overwhelmed with restock inquiries.

Grabity Shampoo features a high concentration of KAIST’s patented active ingredient, LiftMax 308™, a polyphenol-based complex that forms a protective barrier on hair strands to reduce damage. Clinical trials have proven that a single use increases hair thickness by 19.22% and volume by 87.27%.

Its delivery and sustained-release mechanisms were published in the peer-reviewed international journal Advanced Materials Interfaces, offering strong scientific validation.

Grabity is formulated with a 100% vegan blend using EWG Grade 1 ingredients and has earned an Excellent rating from Germany’s Dermatest, fully aligning with the rising global demand for clean beauty. The shampoo is also packaged in sustainable containers made from recycled coconut shells.

Since its launch in Korea just one year ago, Grabity has become a runaway hit—recording over 1.2 million units sold and KRW20 billion (approx. USD15M) in cumulative sales. It famously sold out in just 39 minutes at Korea’s top H&B store Olive Young, with resale prices reaching up to five times retail. Its rapid sellout in Taiwan is seen as a strong signal for further expansion across Asia’s premium beauty market.

A Momo TV Shopping spokesperson stated, “Grabity is the perfect global partner, offering functionality, a compelling brand story, and a commitment to sustainability. We look forward to bringing more world-class brands to Taiwanese consumers.”

About Polyphenol Factory
Polyphenol Factory was founded in 2023 as a startup by faculty members of KAIST (Korea Advanced Institute of Science and Technology). With a team of world-class scientists and young innovators, the company is commercializing cutting-edge technologies derived from natural polyphenols. With the vision of “innovating everyday life through science,” Polyphenol Factory is driving new waves of change in the global market.

Press Contact:
Anna Lee
yimijin@gmail.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/korean-megahit-shampoo-grabity-launches-in-taiwan–just-wash-your-hairand-itll-look-thicker-302463264.html

SOURCE Polyphenol Factory

Jodie Wallis, Global Chief Analytics Officer, Outlines How Manulife is Using AI Responsibly

C$ unless otherwise stated                                             TSX/NYSE/PSE: MFC     SEHK: 945

TORONTO, May 23, 2025 /PRNewswire/ — Manulife’s Responsible AI Principles were shared during the Reuters Momentum AI Summit in New York last month. These principles guide the design, development, and deployment of Manulife’s Artificial Intelligence (AI) solutions, which includes over 43 GenAI use cases in production, as of Q1 2025, an equivalent amount slated to be deployed across the organization by year end and over 450 ideas in evaluation1.

Manulife’s Responsible AI Principles empower the firm to deliver value from AI for its customers, colleagues and society. With the fast pace of change in AI, Manulife will evolve its Principles as it learns and grows, as the industry matures, and as new or updated regulations emerge. Manulife’s Responsible AI Principles are:

To use data and AI in ways that are aligned to the company’s Code of Business Conduct and Ethics and Impact Agenda.To prioritize the safety of customers, colleagues and organization through sound delivery and governance processes.To endeavor to align AI efforts with a commitment to a sustainable future, by designing energy-efficient AI solutions and partnering with companies who share Manulife’s values.To implement practices intended to make AI solutions and their use of data free from bias, explainable, and reliable, while maintaining the appropriate accountability for decision making.To prioritize human agency and empower our colleagues to use AI tools to enhance their skills and experience, knowing these are crucial for the future.To continually learn from and work with industry partners and AI experts to foster innovation and evolve our commitment to Responsible AI.

“As organizations increasingly rely on AI, being committed to responsible AI use is paramount and Manulife is proud to be a responsible AI steward,” says Karen Leggett, Global Chief Marketing Officer for Manulife. “GenAI is enabling us to better serve our customers, find innovative ways of working, and accelerate our ambition of becoming the most digital customer-centric company in our industry. At the same time, Manulife is taking great care to embed ethical AI principles in every application and workflow.”

Manulife is leading by example as Jodie Wallis, Global Chief Analytics Officer for Manulife, spoke at Reuters Momentum AI Summit in New York, where she, alongside industry leaders, discussed the future of artificial intelligence and its impact on global business. In her remarks, Wallis outlined how Manulife is using AI ethically and responsibly, providing benefits to customers while safeguarding their data and privacy.

“We are committed to harnessing AI responsibly, ensuring it aligns to our core values and supports our mission to make decisions easier and lives better,” says Wallis. “Our AI Principles highlight the importance of ethical adoption, and we are dedicated to cultivating a collaborative environment that tackles the complexities of AI while ensuring it remains safe, trustworthy, and beneficial for all.”

Manulife has been actively investing in and scaling AI capabilities since 2016. In the past three years, the firm has significantly increased the valuei enabled through advanced analytics and AI by expanding its AI solutions portfolio and increasing efficiency through data and AI platform investmentsii, all driven by the company’s responsible AI framework.

As of Q1 2025, Manulife has:

Over 43 GenAI use cases in production and over 450 ideas in evaluationApproximately 200 data scientists and machine learning engineersGlobal access to GenAI tools for all colleaguesA GenAI skills-building program for users, leaders and practitioners

The summit also provided a platform for Wallis to discuss the importance of educating and training colleagues on AI technologies.

“Empowering our workforce with the knowledge and skills to harness AI responsibly is crucial to our success and aligns with our commitment to a productive and ethical use of technology,” says Wallis.

Manulife expects its digital investments and capabilities, including AI-enabled enhancements, to generate a threefold return on investment over five years through 2027, with over $600 million of benefits2 realized in 2024 from our digital customer leadership initiatives globally. To learn more about Manulife’s AI progress, visit: manulife.com/AI

Caution regarding forward-looking statements

This document contains forward-looking statements within the meaning of the “safe harbour” provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995 with respect to Manulife’s use of its digital capabilities, including AI and AI-enabled tools, and the expected benefits it expects to realize. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from expectations include but are not limited to general business and economic conditions; changes in laws and regulations with respect to the use of AI-enabled tools; our ability to execute our digital plans and to deploy future digital use cases; our ability to adapt products and services to the changing market; our ability to attract and retain key employees; and our ability to protect our intellectual property and exposure to claims of infringement from others. Additional information about material risk factors that could cause actual results to differ materially from expectations may be found in our most recent annual and interim reports and elsewhere in our filings with Canadian and U.S. securities regulators.

The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof. We do not undertake to update any forward-looking statements, except as required by law.

About Manulife  

Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as ‘MFC’ on the Toronto, New York, and the Philippine stock exchanges, and under ‘945’ in Hong Kong. 
 
Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com. 

Media Contact
Gina Simonis
617-840-4794
GSimonis@Manulife.com